The Lab Rats

The group is developing novel immunotherapies using the Adeno-associated virus (AAV) gene-therapy platform that are capable of not only preventing development of disease, but can also stop preexisting (reverse) disease in mouse models of Multiple Sclerosis.

PRINCIPAL INVESTIGATOR

Brad Hoffman

Dr. Hoffman is an Associate Professor and cellular immunologist with a major interest in immune modulation and tolerance induction using adeno-associated virus (AAV) gene therapy. Dr. Hoffman earned his Ph.D. in Immunology from Temple University School of Medicine in 2006. He subsequently performed postdoctoral research in gene therapy at University of Florida.

Brad Hoffman

UF Pediatric News

Pediatricians encouraged to discuss gun safety

Alexandra K. Byrne, MD, a pediatric resident at the University of Florida College of Medicine, presented findings from a study showing that staff training programs and providing education materials about gun…

Following backlash and support, school board extends mask mandate in Alachua County Public Schools

Dr. Desmond Schatz, the interim physician-in-chief at UF Health Shands Children’s Hospital, said the mandate is a matter of right and wrong. “We need to put moral considerations ahead of…

Alachua County schools see COVID-19 infections, exposures drop

Adrienne Mott-Young, an UF Health Pediatrician and member of the school district’ Scientific Health Advisory Committee, said the county positivity rate should be less than 3% before the school district decides to…

Protect your family this flu season by getting vaccinated

Due to the COVID-19 pandemic, vaccination coverage for the flu dropped throughout the 2020-2021 season. Following social distancing guidelines, improved hand hygiene and proper masking led to decreased rates of flu…